Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

Related Articles

Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

J Psychosom Res. 2015 Oct 13;

Authors: Heller MK, Chapman SC, Horne R

Abstract
OBJECTIVE: Some perceived medication side effects may be ‘normal’ symptoms that patients misattribute to the medication. Using an analogue approach, we tested if medication beliefs predict whether participants misattribute a headache as a side effect and subsequently intend to stop medication.
METHODS: We recruited 690 participants, 223 reporting a past asthma diagnosis. They received information about asthma and Molair, a fictitious asthma treatment modeled on a licensed treatment (montelukast). We varied the description of efficacy and side effects (which did not include headache). Pre-exposure to this information, participants completed the Beliefs about Medicine Questionnaire (BMQ)-General and the Perceived Sensitivity to Medicines Scale (PSM), post-exposure they completed the BMQ-Specific. Participants were asked to imagine they experienced a headache while taking Molair. Finally, they rated whether the headache was a side effect (misattribution) and if they would stop taking Molair (behavioral intention).
RESULTS: Nearly a quarter (170) of participants misattributed the headache to Molair and 69 (10%) subsequently intended to stop Molair. Both outcomes were predicted by general and specific medication beliefs. Odds of misattribution (m) and behavioral intention (i) increased with higher General Harm (ORm=1.90, ORi=2.72), General Overuse (ORm=1.74, ORi=1.56) and Molair Concern beliefs (ORm=1.52, ORi=1.78, all p<.01), but decreased with General Benefit (ORm=0.72, ORi=0.53) and Molair Necessity beliefs (ORm=0.72, ORi=0.70, all p<.05).
CONCLUSION: Symptom misattribution and subsequent intentions to stop Molair were predicted by pre-exposure beliefs about medicines in general and post-exposure beliefs about Molair. Patients with negative medication beliefs may be prone to misattribute symptoms and subsequently stop medication.

PMID: 26519128 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Preventive Asthma Drugs Medication Global Market Research To Reach At CAGR of … – Medgadget.com (blog)

Preventive Asthma Drugs Medication Global Market Research To Reach At CAGR of
Medgadget.com (blog)
MrrBiz215 Latest Research To Innovate The “Global Preventive Asthma Drugs Market 2015-2019? studies the current scenario as well as future market potential of “Pharmaceutical” globally. According to the Global Initiative for Asthma, asthma is a

View full post on asthma – Google News

Asthma Medication May Stunt Growth in Childhood – Newsweek


Newsweek

Asthma Medication May Stunt Growth in Childhood
Newsweek
Certain corticosteroids used to manage symptoms of asthma may stunt growth in children who use the drugs within the first two years of their life, according to research presented Saturday at the 54th Annual European Society for Pediatric Endocrinology …
Asthma: Asthma Medicine Results In Stunted GrowthScience World Report
Asthma Medication Linked to Stunted Growth, Infant StudyNews Every day

all 3 news articles »

View full post on asthma – Google News

AstraZeneca embracing smart inhalers for asthma tracking & medication adherence – iMedicalApps


iMedicalApps

AstraZeneca embracing smart inhalers for asthma tracking & medication adherence
iMedicalApps
Adherium is an Australian company that makes a line of FDA cleared smart inhaler attachments that attach to a range of inhalers for asthma and chronic obstructive pulmonary disease (COPD). These devices, which include a touchscreen display for …

View full post on asthma – Google News

Mo Farah changed asthma medication after moving to work with Alberto Salazar … – Daily Mail


Daily Mail

Mo Farah changed asthma medication after moving to work with Alberto Salazar
Daily Mail
Mo Farah's asthma medication changed after he moved to Portland to work with American coach Alberto Salazar, Sportsmail has learned. The 32-year-old had been diagnosed with asthma as a child but used only a basic inhaler from 'late 2009' according to …
Alberto Salazar must prove innocence or I'll be first person out, says Mo FarahThe Independent
Farah says he is 100 percent cleanWKZO

all 129 news articles »

View full post on asthma – Google News